These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28073801)

  • 1. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M;
    Ann Rheum Dis; 2017 Jul; 76(7):1245-1252. PubMed ID: 28073801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does disease activity at start of biologic therapy influence work-loss in RA patients?
    Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
    Rheumatology (Oxford); 2016 Apr; 55(4):729-34. PubMed ID: 26683196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
    Kristensen LE; Englund M; Neovius M; Askling J; Jacobsson LT; Petersson IF
    Ann Rheum Dis; 2013 Oct; 72(10):1675-9. PubMed ID: 23148309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
    Neovius M; Simard JF; Klareskog L; Askling J;
    Ann Rheum Dis; 2011 Aug; 70(8):1407-14. PubMed ID: 21518724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
    Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson JÅ; Geborek P; Jacobsson LT; Askling J; Neovius M
    Ann Rheum Dis; 2014 May; 73(5):845-53. PubMed ID: 23520035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
    Eriksson JK; Neovius M; Bratt J; Petersson IF; van Vollenhoven RF; Geborek P; Ernestam S
    JAMA Intern Med; 2013 Aug; 173(15):1407-14. PubMed ID: 23817631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
    Kristensen LE; Petersson IF; Geborek P; Jöud A; Saxne T; Jacobsson LT; Englund M
    Rheumatology (Oxford); 2012 Feb; 51(2):243-9. PubMed ID: 21565900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
    Olofsson T; Englund M; Saxne T; Jöud A; Jacobsson LT; Geborek P; Allaire S; Petersson IF
    Ann Rheum Dis; 2010 Dec; 69(12):2131-6. PubMed ID: 20693274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Work ability in rheumatoid arthritis patients: a register study on the prospective risk of exclusion and probability of returning to work.
    Hansen SM; Hetland ML; Pedersen J; Østergaard M; Rubak TS; Bjorner JB
    Rheumatology (Oxford); 2017 Jul; 56(7):1135-1143. PubMed ID: 28371921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.
    Wallman JK; Jöud A; Olofsson T; Jacobsson LTH; Bliddal H; Kristensen LE
    Rheumatology (Oxford); 2017 May; 56(5):716-724. PubMed ID: 28064208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
    Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.
    Manders SH; Kievit W; Braakman-Jansen AL; Brus HL; Hendriks L; Fransen J; van de Laar MA; van Riel PL
    J Rheumatol; 2014 Jul; 41(7):1263-9. PubMed ID: 24833758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
    Raaschou P; Simard JF; Neovius M; Askling J;
    Arthritis Rheum; 2011 Jul; 63(7):1812-22. PubMed ID: 21305513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.
    Verstappen SM; Watson KD; Lunt M; McGrother K; Symmons DP; Hyrich KL;
    Rheumatology (Oxford); 2010 Aug; 49(8):1570-7. PubMed ID: 20444856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
    Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
    Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out.
    Allaire S; Wolfe F; Niu J; Zhang Y; Zhang B; LaValley M
    Arthritis Rheum; 2008 Aug; 59(8):1082-9. PubMed ID: 18668597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with ulcerative colitis miss more days of work than the general population, even following colectomy.
    Neovius M; Arkema EV; Blomqvist P; Ekbom A; Smedby KE
    Gastroenterology; 2013 Mar; 144(3):536-43. PubMed ID: 23232295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Self-Assessed Future Work Ability and Long-Term Sickness Absence, Disability Pension and Unemployment in a General Working Population: A 7-Year Follow-Up Study.
    Lundin A; Kjellberg K; Leijon O; Punnett L; Hemmingsson T
    J Occup Rehabil; 2016 Jun; 26(2):195-203. PubMed ID: 26319413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.